Gekko Brief
AI summaryNov 9 close
Kodiak Sciences moves this week on insider and fund activity, with a Form 4 filing from Baker Bros. Advisors LP, acting as Director and 10% Owner, dated 4 November, alongside two funds, 667, L.P. and Baker Brothers Life Sciences LP, reporting purchases totaling 247,090 common shares at $98.51 per share on 4 and 5 November.
Shares close at $107.10, up 7.9%, sitting above both the 50-day average of $70.95 and the 200-day average of $44.25, with the 50-day above the 200-day. The GekkoIndex reads 48.5, placing KOD in the Neutral zone, down 2.3 over the last 5 readings. The stock trades 26.8% above Gekko Fair Value of $84.44. One-month return stands at 7.2%, three-month at 154.3%, and one-year at 533.7%, with a 52-week high of $107.53 and low of $15.83.
Earnings are due on 12 November 2026, two days away, falling inside a typical 20-trading-day holding window; the last report on 12 August showed an EPS of -1.05 against a -0.96 estimate, with a -5.1% reaction, and 3 beats across the last 8 quarters, averaging a 10.7% absolute move. Insider buying over the last 90 days totals 72 purchases worth $181.1 million. Seasonally, the next 20 trading days have averaged +26.9% across 5 years, rising in 4 of them. Analyst consensus from 7 firms carries 6 buy ratings, 1 hold, and a $121.67 target.